Q Fever (Coxiella Burnetii)

被引:37
|
作者
Pablo Espana, Pedro [1 ]
Uranga, Ane [1 ]
Cilloniz, Catia [2 ,3 ,4 ,5 ]
Torres, Antoni [2 ,3 ,4 ,5 ]
机构
[1] Univ Hosp Galdakao Usansolo, Dept Pulmonol, Bilbao, Spain
[2] Hosp Clin Barcelona, Dept Pneumol, Barcelona, Spain
[3] Univ Barcelona, August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain
[4] Biomed Res Networking Centers Resp Dis CIBERES, Barcelona, Spain
[5] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain
关键词
Coxiella burnetii; Q fever; epidemiology; pathogenesis; antigenic phase variation; diagnosis; treatment; COGNITIVE-BEHAVIORAL THERAPY; PHASE-I; EPIDEMIOLOGIC FEATURES; DOXYCYCLINE TREATMENT; FOLLOW-UP; RAW-MILK; INFECTION; DIAGNOSIS; ENDOCARDITIS; MONOCYTES;
D O I
10.1055/s-0040-1710594
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Q fever is a zoonotic infectious disease caused by theCoxiella burnetiibacterium. It is an obligate intracellular pathogen with a high infection capacity that proliferates exclusively in an acidified medium, forming a lysosome-like vacuole. It presents a peculiar phenomenon called "antigenic phase variation," produced by a modification in the complexity of the membrane lipopolysaccharides. Q fever can be found worldwide and presents variable clinical features and geographical distribution. It mostly affects people in rural areas who are in contact with animals. The most common type of transmission to humans is via the inhalation of aerosols containing the pathogen, especially those formed from placental derivatives. Wild animals, domestic animals, and ticks are the principal reservoirs. Diagnosis is mainly made by indirect methods such as serology or by direct methods such as microbiological cultures or tests that detect the specific DNA. Typically, there are two clinical presentations: the acute disease, which is more frequent and often asymptomatic, and a persistent focalized infection in 4 to 5% of patients, generally with a poor evolution. Treatment of the acute form in both children and adults consists of administering doxycycline, while persistent focalized infection should be treated with at least two antibiotics, such as doxycycline and hydroxychloroquine. Several measures should be undertaken to minimize exposure among people working with animals or handling birth products. Different vaccines have been developed to prevent infection, though few data are available.
引用
收藏
页码:509 / 521
页数:13
相关论文
共 50 条
  • [1] Q fever and prevalence of Coxiella burnetii in milk
    Pexara, Andreana
    Solomakos, Nikolaos
    Govaris, Alexander
    TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2018, 71 : 65 - 72
  • [2] From Q Fever to Coxiella burnetii Infection: a Paradigm Change
    Eldin, Carole
    Melenotte, Clea
    Mediannikov, Oleg
    Ghigo, Eric
    Million, Matthieu
    Edouard, Sophie
    Mege, Jean-Louis
    Maurin, Max
    Raoult, Didier
    CLINICAL MICROBIOLOGY REVIEWS, 2017, 30 (01) : 115 - 190
  • [3] Coxiella burnetii, the Q fever agent
    Boarbi, Samira
    Fretin, David
    Mori, Marcella
    CANADIAN JOURNAL OF MICROBIOLOGY, 2016, 62 (02) : 102 - 122
  • [4] Coxiella burnetii Endocarditis Detected in a Case Followed with Fever of Unknown Reason: Q Fever Case Report
    Hosgel Sevdimbas, Sezin
    Kurtaran, Behice
    Candevir, Aslihan
    Kuscu, Ferit
    Tasova, Yesim
    FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2024, 29 (04): : 540 - 544
  • [5] Recent progress in glycomics and proteomics of the Q fever bacterium Coxiella burnetii
    Toman, R.
    Skultety, L.
    Palkovicova, K.
    Florez-Ramirez, G.
    Vadovic, P.
    ACTA VIROLOGICA, 2013, 57 (02) : 229 - 237
  • [6] Molecular Typing of Coxiella burnetii (Q Fever)
    Massung, Robert F.
    Cutler, Sally J.
    Frangoulidis, Dimitrios
    COXIELLA BURNETII: RECENT ADVANCES AND NEW PERSPECTIVES IN RESEARCH OF THE Q FEVER BACTERIUM, 2012, 984 : 381 - 396
  • [7] Clinical microbiology of Coxiella burnetii and relevant aspects for the diagnosis and control of the zoonotic disease Q fever
    Roest, Hendrik I. J.
    Bossers, Alex
    van Zijderveld, Fred G.
    Rebel, Johanna M. L.
    VETERINARY QUARTERLY, 2013, 33 (03) : 148 - 160
  • [8] A combination of interferon-gamma and interleukin-2 production by Coxiella burnetii-stimulated circulating cells discriminates between chronic Q fever and past Q fever
    Schoffelen, T.
    Sprong, T.
    Bleeker-Rovers, C. P.
    Wegdam-Blans, M. C. A.
    Ammerdorffer, A.
    Pronk, M. J. H.
    Soethoudt, Y. E. P.
    van Kasteren, M. E. E.
    Herremans, T.
    Bijlmer, H. A.
    Netea, M. G.
    van der Meer, J. W. M.
    Joosten, L. A. B.
    van Deuren, M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (07) : 642 - 650
  • [9] Q fever and seroprevalence of Coxiella burnetii in domestic ruminants
    Pexara, Andreana
    Solomakos, Nikolaos
    Govaris, Alexander
    VETERINARIA ITALIANA, 2018, 54 (04) : 265 - 279
  • [10] Introduction to Measurement of Avidity of Anti-Coxiella burnetii IgG in Diagnosis of Q Fever
    Luciani, Lea
    L'Ollivier, Coralie
    Million, Matthieu
    Amphoux, Bernard
    Sophie, Edouard
    Raoult, Didier
    JOURNAL OF CLINICAL MICROBIOLOGY, 2019, 57 (10)